THERAPY FOR LEUKEMIA

• 收藏
• 分享

专利权人:

CHILDREN'S HOSPITAL MEDICAL CENTER

发明人:

Mohammad AZAM,Meenu KESARWANI

申请号：

US15866544

公开号：

US20180125799A1

申请日:

2018.01.10

申请国别(地区):

US

年份:

2018

代理人:

摘要：

A pharmaceutically acceptable composition and method for leukemia therapy in a patient in need of such therapy. The composition contains, as the only active agents, the combination of (a) an inhibitor of c-Fos, (b) an inhibitor of Dusp-1, and (c) an inhibitor of BCR-ABL tyrosine kinase. The composition is administered to the patient in a dosing regimen for a period sufficient to provide therapy for leukemia.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/